Urinary Tract Infection in Women Clinical Practice Guidelines (2019)

American Urological Association (AUA), Canadian Urological Association (CUA), and Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)

This is a quick summary of the guidelines without analysis or commentary. For more information, go directly to the guidelines by clicking the link in the reference.

June 03, 2019

Clinical guidelines on urinary tract infection in women were released in May 2019 by the American Urological Association (AUA), Canadian Urological Association (CUA), and the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU).[1]

The American Urological Association (AUA) has issued its first guideline for the diagnosis and treatment of uncomplicated recurrent urinary tract infections (UTIs), emphasizing the importance of cultures and antibiotic stewardship.

Evaluation

Women presenting with recurrent lower urinary tract infections (rUTI) should undergo a complete patient history and pelvic examination.

A diagnosis of rUTI must be based on documented positive urine culture results in association with prior symptomatic episodes.

An initial urine specimen that may be contaminated should prompt a repeat urine study; collection of a catheterized specimen should be considered.

Index patients presenting with rUTI should not routinely undergo upper tract imaging and cystoscopy.

Before beginning treatment in patients with rUTI, urinalysis, urine culture, and sensitivity should be performed for each symptomatic acute cystitis episode.

Select patients with rUTI with acute episodes may be offered patient-initiated treatment (self-start treatment) while urine culture results are pending.

Asymptomatic Bacteriuria

Surveillance urine testing, including urine culture, should not be performed in asymptomatic patients with rUTI.

Asymptomatic bacteriuria should not be treated.

Antibiotic Treatment

Symptomatic UTIs in women should be treated with first-line therapy (ie, nitrofurantoin, TMP-SMX, fosfomycin) and should depend on local antibiogram.

The duration of antibiotic therapy for rUTI in patients with acute cystitis episodes should be as short as is reasonable (typically no longer than 7 days).

rUTIs in patients with acute cystitis that has shown resistance to oral antibiotics on urine culture may be treated with culture-directed parenteral antibiotics for as short a course as is reasonable (typically no longer than 7 days).

Antibiotic Prophylaxis

After discussing the risks, benefits, and alternatives, antibiotic prophylaxis may be prescribed to reduce the risk of future UTIs in women of all ages previously diagnosed with UTI.

Nonantibiotic Prophylaxis

Cranberry prophylaxis may be offered to women with rUTI.

Follow-up Evaluation

Posttreatment urinalysis or urine culture to test for cure should not be performed in asymptomatic patients.

UTI symptoms that persist after antimicrobial therapy should prompt repeat urine culture to guide further treatment.

Estrogen Therapy

Vaginal estrogen therapy with no contraindications should be recommended to perimenopausal and postmenopausal women with rUTIs to reduce the risk of future UTI.

For more information, please go to Urinary Tract Infection (UTI) and Cystitis (Bladder Infection) in Females.

For more Clinical Practice Guidelines, please go to Guidelines.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....